The Medical University of Vienna, located in Vienna, Austria, is one of the oldest medical schools in Europe, with its origins dating back to 1365 when it was part of the University of Vienna. In 2004, it became an independent institution. The university specializes in medical education, research, and healthcare services, offering a wide range of programs in medicine and dentistry. It is renowned for its contributions to medical science, particularly in fields such as immunology, cancer research, and neuroscience. The Medical University of Vienna also operates closely with the Vienna General Hospital, one of the largest hospitals in Europe, providing extensive clinical training opportunities for students and serving as a major hub for clinical trials and medical research. The institution is committed to advancing medical innovations and improving patient care through its state-of-the-art facilities and a strong emphasis on interdisciplinary collaboration.
Research findings may enhance regulated application in neuropsychiatric conditions. The global conversation around using 3,4-methylenedioxy-N-methylamphetamine (MDMA), popularly known as “ecstasy,” in psychotherapy for mental illnesses…
Link between salt intake and stomach cancer demonstrated in Western countries for the first time In many Asian nations where high-salt diets are common, the…
The new model has the potential to accelerate research into neurodegenerative diseases. In a joint project between MedUni Vienna and TU Wien, the world’s first…
Advancements in understanding the disease could bring about a paradigm shift. For a long time, osteoarthritis was believed to stem from wear and tear in…
People suffering from obesity are at a significantly greater risk of also developing mental disorders. This applies to all age groups, whereby women are more…
Activating the auricular vagus nerve provides anti-inflammatory effects in severe COVID-19 cases. A system out of balance When a virus – such as SARS-CoV-2 –…
Vaccine developed at MedUni Vienna delivers promising data. The preclinical data for a vaccine developed at MedUni Vienna to protect against SARS-CoV-2 indicates that it…
Around 20% of those who have recovered from COVID-19 fail to develop immune protection against SARS-CoV-2, according to a MedUni Vienna research team led by…
MedUni Vienna study provides new information for a better understanding of the disease – and potential biomarkers for vaccine development. In a study recently published…